Moderna Inc. stock outperforms the market despite the day’s losses


Actions of Moderna Inc. MRNA,
lost 0.04% to $ 70.52 on Tuesday, in what turned out to be a global trading session for the stock market, with the NASDAQ Composite Index COMP,
drop 0.29% to 11,085.25 and Dow Jones Industrial Average DJIA,
down 0.48% to 27,452.66. The fall in the stock broke a two-day streak in a row. Moderna Inc. closed $ 24.69 below its 52-week high ($ 95.21), which the company hit on July 17.

The title showed a mixed performance against some of its competitors on Tuesday, such as AbbVie Inc. ABBV,
fell 0.45% to $ 86.89 and Amgen Inc. AMGN,
+ 0,51%
rose 0.51% to $ 248.30. Transaction volume (5.3 M) remained 9.0 million below its 50-day average volume of 14.3 M

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.


Please enter your comment!
Please enter your name here